Showing 6011-6020 of 8712 results for "".
- FDA Grants 510(k) Clearance to Chemence Medical’s Exofin Fusion Redesignhttps://practicaldermatology.com/news/fda-grants-510k-clearance-to-chemence-medicals-exofin-fusion-redesign/2460736/The U.S. Federal Drug Administration gave its nod to Chemence Medical’s redesigned exofin fusion skin closure system. Exofin fusion combines a self-adhering flexible mesh strip and a fast-curing 2-octyl cyanoacrylate topical adhesive to close and seal incisions while forming an im
- Pediatric Dermatology Incomes Up; Demand Persists: Surveyhttps://practicaldermatology.com/news/pediatric-dermatology-incomes-up-demand-persists-survey/2460735/Median total compensation for pediatric dermatologists has increased 37 percent since 2014, results of The Society for Pediatric Dermatology’s (SPD) latest compensation report show. The
- Survey: Parents Extremely Worried About the Physical and Emotional Toll that Severe Acne Takes on Teenshttps://practicaldermatology.com/news/survey-parents-extremely-worried-about-the-physical-and-emotional-toll-that-severe-acne-takes-on-teens/2460734/Parents are very worried about the effects of severe acne on their teens, according to a new survey sponsored by Sun Pharma, in collaboration with the American Acne and Rosacea Society (AARS). The survey, which polled 250 parents of teenagers with severe nodular or cystic acne, sho
- Hydrafacial Expands CONNECT Certification Programhttps://practicaldermatology.com/news/hydrafacial-expands-connect-certification-program/2460733/The HydraFacial Company is expanding the HydraFacial CONNECT certification program, making it available to aesthetic professionals nationwide. This past month, the program successfully graduated its first class of CONNECT Masters, the highest distinction in the certification progr
- About Three-Quarters of Americans Wish They Had Taken Better Care of Themselves During the Pandemichttps://practicaldermatology.com/news/about-three-quarters-of-americans-wish-they-had-taken-better-care-of-themselves-during-the-pandemic/2460732/Seventy-four percent of people say they wish they’d taken better care of themselves this past year, including many admitting to sub-par skincare and grooming, finds a new survey of more than 2,022 people by
- Fat Grafting Shows Promise for Cancer Patients with Radiation-induced Skin Injuryhttps://practicaldermatology.com/news/fat-grafting-shows-promise-for-cancer-patients-with-radiation-induced-skin-injury/2460730/As cancer survival rates improve, more people are living with the aftereffects of cancer treatment including chronic radiation-induced skin injury. Fat grafting procedures may unleash the healing and regenerative power of the body's natural adipose stem cells (ASCs). "Prelimina
- Verrica CMO Dr. Gary Goldenberg Elected to Membership in the American Dermatological Associationhttps://practicaldermatology.com/news/verrica-cmo-dr-gary-goldenberg-elected-to-membership-in-the-american-dermatological-association/2460728/Gary Goldenberg, MD has been elected as an active member into the American Dermatological Association (ADA). Dr. Goldenberg is Verrica’s Chief Medical Officer. “We congratulate Gary on his well-deserved election into the ADA, one of the highest honors in d
- Sincerus Completes Financing With SWK To Support Demand For Customized Dermatologic Medicineshttps://practicaldermatology.com/news/sincerus-completes-financing-with-swk-to-support-demand-for-customized-dermatologic-medicines/2460727/Sincerus Pharmaceuticals, the parent company of Prescriber's Choice and Sincerus Florida, completed a major new round of growth financing with SWK Holdings Corporation, representing the largest investment into the company to date. Use of proceeds will include the build-out and expansion of a
- Dermata Doses First Patient in Phase 1b Trial of Topical DMT310 for Mild-to-Moderate Psoriasishttps://practicaldermatology.com/news/dermata-doses-first-patient-in-phase-1b-trial-of-topical-dmt310-for-mild-to-moderate-psoriasis/2460726/Dermata Therapeutics, Inc. dosed its first patient in a Phase 1b trial of DMT310 for the treatment of mild-to-moderate psoriasis. DMT310 is currently being investigated to treat multiple inflammatory skin diseases. It consists of a once-weekly topical treatment with both mech
- SkinKick Launches Acne System at Ulta Beautyhttps://practicaldermatology.com/news/skinkick-launches-acne-system-at-ulta-beauty/2460725/SkinKick’s Acne KickPRO™ Duo is the brand’s first Ulta Beauty™ exclusive. The two-step homeopathic treatment for acute acne, began rolling out in February at Ulta Beauty online and in-stores nationwide. SkinKick is a pa